SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Del Porto JA. Rev. Bras. Med. 2002; 59(SPEC. ISS.): 97-107.

Copyright

(Copyright © 2002, Editorial Sul Americana S A)

DOI

unavailable

PMID

unavailable

Abstract

The author begin giving epidemiologic data, as the more frequent complaints, poiting out the anamnesis' importance, not only to detect the "secondary" depressions (with origin in organic diseases) as to detect more specific depression symptoms. Then presents the clinical features of depression taking into consideration: 1) psychic; 2) physiologic symptoms; and 3) behavioural evidences that establish the diagnosis, such as the depressive humor, satisfaction feeling reduction, fatigue, thinking reduced capacity, sleep, eating and behavioural disturbances (social detriment, cry, suicide tendencies, psychomotor retardation), pointing out the frequent anxiety association. The author also show the circadian rythm modification and sequentially presents the bipolar disorders spectrum and depression: (bipolar I, bipolar II, associated with hypomania, recurrent depression - without hypomania, with familiar history) the so-called bipolat III (pseudo unipolar); he follows with the DSM-IV guidelines, discussing the several diseases spectrum. Besides the classification data, he defines the depression limits and the personality disorders limits, presenting also the differential diagnostic with other psychiatric disorders. Regarding to treatment of the depressive disorders, the author presents the therapeutic plan (association with the patient, disease education approach with the family, pharmacologic or eletroconvulsant facilities and the psychoterapy). About the antidepressive (AD) agents, the author describes the triciclic and tetraciclics AD, the selective reuptake serotonine inhibitors (SRSI), that are more recent, concluding with other AD of newer therapeutic introduction. For all the presented drugs, the side-effects, drug interactions and tolerability, are presented.


Language: pt

Keywords

alprazolam; amitriptyline; anafranil sr; analgesic agent; anamnesis; antiarrhythmic agent; antidepressant agent; article; astemizole; behavior disorder; beta adrenergic receptor blocking agent; bipolar disorder; carbamazepine; chloramphenicol; cholinergic receptor blocking agent; cimetidine; circadian rhythm; citalopram; clinical feature; clomipramine; depression; Depression; diarrhea; differential diagnosis; disease classification; disulfiram; drug tolerability; fatigue; feeding behavior; fluoxetine; fluvoxamine maleate; human; hypnotic agent; hypomania; hypotension; imipramine; insomnia; maprotiline; Mood disorders; nausea; neuroleptic agent; norfluoxetine; nortriptyline; paroxetine; patient education; personality disorder; psychomotor retardation; psychotherapy; reboxetine; satisfaction; serotonin uptake inhibitor; sertraline; sexual dysfunction; sleep; somnolence; suicide; terfenadine; tetracycline derivative; thinking; tofranil pamoato; tramadol; tremor; tricyclic antidepressant agent; unindexed drug; venlafaxine

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print